# Prevention of Cognitive Decline in Older Adults With Low Dha/Epa Index in Red Blood Cells

> **NCT03691519** · PHASE3 · COMPLETED · sponsor: **University Hospital, Toulouse** · enrollment: 774 (actual)

## Conditions studied

- Alzheimer Disease

## Interventions

- **DRUG:** Omega-3 treatment
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT03691519
- **Lead sponsor:** University Hospital, Toulouse
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-04-17
- **Primary completion:** 2020-03-31
- **Final completion:** 2020-03-31
- **Target enrollment:** 774 (ACTUAL)
- **Last updated:** 2023-08-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03691519

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03691519, "Prevention of Cognitive Decline in Older Adults With Low Dha/Epa Index in Red Blood Cells". Retrieved via AI Analytics 2026-07-25 from https://api.ai-analytics.org/clinical/NCT03691519. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*